Stephen Keller Net Worth

The estimated Net Worth of Stephen Keller is at least 231 千$ dollars as of 6 November 2023. Stephen Keller owns over 2,000 units of Envista Corp stock worth over 230,555$ and over the last few years Stephen sold NVST stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Stephen Keller NVST stock SEC Form 4 insiders trading

Stephen has made over 1 trades of the Envista Corp stock since 2023, according to the Form 4 filled with the SEC. Most recently Stephen bought 2,000 units of NVST stock worth 43,060$ on 6 November 2023.

The largest trade Stephen's ever made was buying 2,000 units of Envista Corp stock on 6 November 2023 worth over 43,060$. On average, Stephen trades about 500 units every 0 days since 2023. As of 6 November 2023 Stephen still owns at least 13,070 units of Envista Corp stock.

You can see the complete history of Stephen Keller stock trades at the bottom of the page.

What's Stephen Keller's mailing address?

Stephen's mailing address filed with the SEC is C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821.

Insiders trading at Envista Corp

Over the last 5 years, insiders at Envista Corp have traded over 35,099,063$ worth of Envista Corp stock and bought 101,717 units worth 1,939,832$ . The most active insiders traders include Corp /De/ Danaher、Vivek Jain、Wendy Carruthers. On average, Envista Corp executives and independent directors trade stock every 31 days with the average trade being worth of 320,413$. The most recent stock trade was executed by Paul A Keel on 13 August 2024, trading 30,000 units of NVST stock currently worth 506,100$.

What does Envista Corp do?

we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho

Complete history of Stephen Keller stock trades at Envista Corp

Envista Corp executives and stock owners

Envista Corp executives and other stock owners filed with the SEC include:

• Amir Aghdaei,
  President, Chief Executive Officer, Director
• Amir Aghdaei,
  Pres, CEO & Director
• Patrik Eriksson,
  Senior Vice President
• Curt Bludworth,
  Chief Human Resource Officer, Senior Vice President
• Howard Yu,
  Chief Financial Officer, Senior Vice President
• Patrik Eriksson,
  Sr. VP & Pres of Nobel Biocare
• Howard H. Yu,
  Sr. VP & CFO
• Mark E. Nance,
  Sr. VP, Gen. Counsel & Sec.
• Jean-Claude E. Kyrillos,
  Sr. VP and Pres of Imaging & DTX
• Scott Huennekens,
  Independent Chairman of the Board
• Christine Tsingos,
  Independent Director
• Wendy Carruthers,
  Independent Director
• Kieran Gallahue,
  Independent Director
• Daniel Raskas,
  Director
• John Bedford,
  Vice President - Investor Relations
• Gayle Sheppard,
  Independent Director
• Vivek Jain,
  Independent Director
• Mischa Reis,
  Senior Vice President - Strategy and Corporate Development
• Jean-Claude Kyrillos,
  Senior Vice President and President of the KaVo Kerr Business
• Jeffrey Kappler,
  Senior Vice President
• Mark Nance,
  Senior Vice President, General Counsel, Secretary
• Curt W. Bludworth,
  Sr. VP & Chief HR Officer
• Mischa M. Reis,
  Sr. VP of Strategy & Corp. Devel.
• Juan Arbona,
  Chief Compliance Officer
• John C. Moten,
  VP of Investor Relations
• Kari-Lyn Moore,
  VP & Chief Accounting Officer
• Robert Befidi,
  President, Diagnostics
• Paul A Keel,
  Chief Executive Officer
• Corp /De/ Danaher,
  10% owner
• William K Daniel,
  Director
• Hans Geiselhoeringer,
  SENIOR VICE PRESIDENT
• Eric Conley,
  SVP, Orthodontics
• Barbara B. Hulit,
  Director
• Stephen Keller,
  Principal Financial Officer
• Faez C Kaabi,
  Chief Accounting Officer
• Eric D. Hammes,
  Chief Financial Officer